Sharenet Sites 
Sharenet Sites
IMU - Imuniti Holdings Limited - Proposed dual listing on the AIM Market of the London Stock Exchange IMUNITI HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration Number 2004/002282/06) Share code: IMU ISIN: ZAE000089199 ("Imuniti" or the "Company") PROPOSED DUAL LISTING ON THE AIM MARKET OF THE LONDON STOCK EXCHANGE Imuniti Holdings Limited is pleased to announce that it intends to seek an admission of its shares to trading on the AIM Market of the London Stock Exchange ("AIM"). In order to pursue this listing, the company requires South African Reserve Bank ("SARB") approval. SARB approval will not be granted until such time as Imuniti shareholders have been notified of the company`s intention to seek a dual listing on AIM. Therefore the purpose of this announcement is to notify shareholders and satisfy the SARB request, in order that the company may compile its Reserve Bank application and submit same, and once it has received SARB approval, proceed with the application for a dual listing. The company has not yet approached the London Stock Exchange nor AIM for approval for the proposed listing, and such approval has therefore not yet been granted. The results of the clinical trials which were announced on SENS on 23 March 2011 has initiated various talks with AIDS funding organisations in addition to the already existing partnership that Edge to Edge Global Investments Limited ("E2E") has with the African Forum . Treatment for vast amounts of AIDS victims who live in Africa is being supported by these funding organisations. Imuniti Holdings Limited has signed an exclusive manufacturing agreement with E2E for the Imuniti Nutritional Supplement Combo ("ISCP") as per the announcement on SENS dated 14 June 2011, which is the product used in these clinical trials. The funding organisations will assist in the roll-out of the Distribution Units for the ISCP across South Africa initially. This will result in a large increase in the manufacture of the ISCP by the company and the working capital and capital expenditure required for this will be provided by the capital raised on the dual listing. With the listing on AIM, the company believes it will benefit from improved access to global investors and global institutional support in the United Kingdom ("UK"). UK and European institutional investors are very strong supporters of African focused companies. The proposed AIM listing would allow UK and European shareholders to trade more freely in the company`s shares. Durban 22 June 2011 Designated Advisor Arcay Moela Sponsors (Proprietary) Limited Date: 22/06/2011 14:41:13 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
